‘It should send shock waves to the White House’: Backlash over FDA approval of Biogen’s Alzheimer’s drug is spreading
A Harvard Medical School professor who resigned from a US Food and Drug Administration advisory panel over approval of a controversial Alzheimer’s treatment called the agency’s decision “perhaps the worst” drug authorization in its recent history.
What to know about the fallout from the FDA decision to approve Biogen’s Alzheimer’s drug
A Harvard Medical School professor who resigned from a US Food and Drug Administration advisory panel over approval of a controversial Alzheimer’s treatment called the agency’s decision “perhaps the worst” drug authorization in its recent history.
BLIND SPOT
An 11-month Globe investigation found that people nationwide are dying in crashes caused by drivers who should have had their licenses suspended. One in 10 US drivers has at least one offense — from speeding to vehicular homicide — that isn’t reflected on their driving record.
Support Real Journalism
Subscribe to the Globe for just 99 cents